Table 3 Characteristics of ESBL E. coli from poultry, colonization and infection in humans in Gabon
Chicken meat (n = 17) | Carriage (n = 16) | Infection (n = 10) | ||
|---|---|---|---|---|
Phylogenetic group | A | 13 (76.5%) | 9 (56.3%) | 2 (20%) |
B1 | 3 (17.7%) | 4 (25.0%) | 3 (30%) | |
B2 | - | 2 (12.5%) | 3 (30%) | |
D | 1 (5.9%) | 1 (6.3%) | 2 (20%) | |
Beta lactamases | CTX-M 1 | 4 (23.5%) | - | - |
CTX-M 14 | 6 (35.3%) | - | - | |
CTX-M 15 | - | 16 (100%) | 9 (90%) | |
CTX-M 27 | - | - | 1 (10%) | |
CTX-M 32 | 1 (5.9%) | - | - | |
TEM | 6 (35.3%) | 7 (43.8%) | 3 (30%) | |
SHV | 7 (41.2%) | - | 1 (10%) | |
Antibiotic resistance, tested substances | Piperacillin/Tazobactam | 1 (5.9%) | 5 (31.2%) | 1 (10%) |
Cefuroxim | 15 (88.2%) | 16 (100%) | 10 (100%) | |
Cefotaxim | 12 (70.6%) | 16 (100%) | 10 (100%) | |
Ceftazidim | 7 (41.2%) | 14 (87.5%) | 10 (100%) | |
Gentamicin | 6 (35.3%) | 5 (31.2%) | 4 (40%) | |
Ciprofloxacin | 8 (47.1%) | 9 (56.2%) | 8 (80%) | |
Cotrimoxazole | 3 (17.6%) | 15 (93.8%) | 10 (100%) |